Kenya: Pharmacy Board Cautions Kenyans Against Off-Label Use of Ozempic for Slimming

Kenya: Pharmacy Board Cautions Kenyans Against Off-Label Use of Ozempic for Slimming

Nairobi -- The Pharmacy and Poisons Board (PPB) has issued a safety alert warning Kenyans against the unsupervised use of Semaglutide-containing drugs such as Ozempic for weight loss, citing potential health risks.

Poisons Board warns against misuse of Ozempic for weight loss

Pharmacy and Poisons Board cautions public against using semaglutide, also known as Ozempic for weight loss, says it's a prescription-only-drug for treating type 2 diabetes.

Gov't warns Kenyans against use of Ozempic for weight loss

The Ministry of Health, through the Pharmacy and Poisons Board (PPB), has issued a cautionary advisory to members of the public against the off-label use of Semaglutide-containing compounds, popularly marketed under brand names such as Ozempic, for weight loss.

PPB warns against unsupervised Ozempic use

The Pharmacy and Poisons Board warns Kenyans against off-label or unsupervised use of semaglutide injections like Ozempic, citing safety concerns and risks from falsified products.

Why Kenya Is Warning Against the Misuse of Ozempic

Globally, Ozempic has been branded on social media as a “miracle weight-loss jab.” Influencers and celebrities are openly endorsing it, driving demand even among people without diabetes

Pharmacy Board cautions Kenyans against off-label use of Ozempic for slimming

NAIROBI, Kenya, Aug 19 – The Pharmacy and Poisons Board (PPB) has issued a safety alert warning Kenyans against the unsupervised use of Semaglutide-containing drugs such as Ozempic for weight loss, citing potential health risks. In a public notice released Tuesday, the PPB stressed that Semaglutide is a prescription-only medicine, approved strictly for the treatment of adults with inadequately controlled type 2 diabetes mellitus. Although the dr…